Polymeric Micelle Compositions for Gene Delivery
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current gene delivery methods, such as viral vectors, face limitations due to immunogenicity, mutagenesis, and size constraints, while nonviral vectors like polymer nanoparticles struggle with nucleic acid stability and cytotoxicity, particularly in maintaining effective delivery of larger nucleic acids for gene therapies.
Innovation Solution
The development of polymeric micelle compositions where a nucleic acid is reversibly bound to a polycation-containing block copolymer and embedded within a hydrophobic core, forming a 'polyplex-in-hydrophobic-core' (PIHC) structure, which includes a matrix of condensed hydrophobic chains as a physical barrier, enhancing stability and delivery efficiency.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Productivity
If viral delivery vectors are used, then transfection efficiency is improved, but immunogenicity and mutagenesis risks increase
Solution Approach 1:
The patent employs nonviral polymeric vectors instead of viral vectors, using biodegradable polymers that are metabolized by the body without causing long-term immunogenicity or mutagenesis. These disposable-like nonviral carriers achieve sufficient transfection efficiency for clinical applications while avoiding the persistent safety concerns of viral systems.
Solution Approach 2:
The patent creates composite polymeric micelle structures combining hydrophobic blocks for stability and nucleic acid binding, and hydrophilic PEG blocks for biocompatibility and steric protection. This composite architecture achieves viral-level transfection efficiency while maintaining the safety profile of nonviral systems.
2Object-affected harmful factors
If nonviral vectors are used, then safety is improved, but transfection efficiency and nucleic acid delivery capability deteriorate
Solution Approach 1:
The patent nests the nucleic acid payload within a polyplex core, which is then embedded within a hydrophobic micelle core, surrounded by a hydrophilic PEG shell. This nested hierarchical structure protects the nucleic acid while enabling efficient cellular uptake and transfection, achieving safety and efficacy simultaneously.
Solution Approach 2:
The patent applies different functional properties to different regions of the vector: the polycationic core provides strong nucleic acid binding and cellular uptake capability, while the PEG shell provides biocompatibility and steric protection. This local differentiation enables high transfection efficiency without sacrificing safety.
3Ease of operation
If PEG chains are added to polyplex micelles, then blood dispersibility and steric shielding are improved, but nuclease protection over long exposure times deteriorates
Solution Approach 1:
The patent extracts the nucleic acid payload from the PEG shell region and embeds it deeply within the hydrophobic micelle core, surrounded by condensed hydrophobic chains. This spatial separation removes the nucleic acid from the PEG chains, eliminating the pathway for nuclease access while preserving the PEG shell's dispersibility function.
Solution Approach 2:
The patent creates a composite structure where the hydrophobic core provides dense physical barrier protection against nucleases, while the PEG shell provides colloidal stability and steric shielding. The combination achieves both blood dispersibility and reliable long-term nuclease resistance.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
This approach provides stable encapsulation and targeted delivery of nucleic acids, reducing cytotoxicity and improving transfection efficiency, while allowing for the delivery of larger nucleic acid molecules, thus overcoming the limitations of existing methods.
Implementation Method 1
a nucleic acid reversibly bound to the polycation-containing block copolymer
Implementation Method 2
a matrix of condensed hydrophobic chains
Data Source
AI summary
The present invention relates to polymeric micelle compositions. More specifically, the present invention relates to polymeric micelle compositions for gene delivery.